Rosalind Advisors »

Avalo Therapeutics Ord shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 75k 14.93

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Xeris Pharmaceuticals (XERS)
Fennec Pharmaceuticals (FENC)
Savara (SVRA)
Vaxcyte (PCVX)
Eyepoint Pharmaceuticals Com New (EYPT)
X4 Pharmaceuticals Com New (XFOR)
Vor Biopharma Com New (VOR)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Cybin Com New (HELP)
Cg Oncology (CGON)
Inspiremd (NSPR)

View all positions for Rosalind Advisors

Top funds holding Avalo Therapeutics Ord

FMR
Caligan Partners
BVF
venBio Select Advisor
Affinity Asset Advisors
Logos Global Management
Nantahala Capital Management
UBS Group
Caption Management
Point72 Asset Management
Farallon Capital Management
Rtw Investments
Adage Capital Partners GP
Millennium Management
TCG Crossover Management

View all funds holding Avalo Therapeutics Ord